according to the ap , neuronetics will hear word from the fda on january , regarding whether its transcranial magnetic stimulation tms treatment will receive fda approval for treating depression you may recall that the previous date for fda approval was delayed , as tms was to scheduled for an fda decision in october according to the ap , fda postponed the meeting due to general scheduling conflicts , according to malvern pennsylvania based neuronetics if you insist , we ll buy that story brief review of tms therapy here